TMJ NextGeneration(TM) Feasibility Study
Bruxoff
A Feasibility Study of the Bruxoff™ Device to Assess EMG Activity in Subjects Diagnosed With Sleep Bruxism Using TMJ NextGeneration(TM)
1 other identifier
interventional
10
1 country
2
Brief Summary
The study is an open-label, prospective, single-center, non-randomized feasibility study of the Bruxoff(TM) device to identify EMG activity associated with bruxism, and to assess the impact of the TMJ NextGeneration(TM) device upon the occurrence of night-time bruxism events and incidence of migraines and headache in subjects diagnosed with sleep bruxism.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Nov 2014
Shorter than P25 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 2, 2014
CompletedFirst Posted
Study publicly available on registry
October 6, 2014
CompletedStudy Start
First participant enrolled
November 1, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2015
CompletedJune 10, 2015
June 1, 2015
3 months
October 2, 2014
June 8, 2015
Conditions
Outcome Measures
Primary Outcomes (1)
Effectiveness of Bruxoff(TM) to measure EMG activity in bruxing subjects using the TMJ NextGeneration(TM) device.
baseline and 8 weeks
Study Arms (1)
Feasibility
OTHERAssessing EMG activity with Bruxoff(TM) device
Interventions
The TMJ NextGeneration(TM) device consists of a pair of small, hollow ear inserts. These ear inserts are custom-fit to each subject's ear canals. The devices rest in the outer third of the ear canal and have a small retraction post that allows for removal of the device from the ear. The devices conform to the shape of the ear canal when the jaw is in the open position and permit full passage of sound into each ear. The mechanisms of action of the inserts are to support the TMJ and associated secondary musculature to reduce strain in the TMJ area and to provide cognitive awareness to the wearer regarding para-functional habits, i.e., jaw clenching.
Eligibility Criteria
You may qualify if:
- Subjects at least 18 years of age;
- Subject has had a diagnosis of sleep bruxism;
- Subject has been medically screened and diagnosed by a physician as having headaches and/or migraines;
- Subject is willing to comply with the usage instructions for the Bruxoff device;
- Is able to read and understand the ICF and has voluntarily provided written informed consent.
- Subject is able to open their mouth at least 17 mm to be fitted for the TMJ NextGenerationTM device;
- Male Subjects are willing to have a clean shaven face on the nights that the Bruxoff device will be used;
- Subject agrees that when using the Bruxoff device to keep their cellular phone in another room.
You may not qualify if:
- Subjects with any physical or behavioral disorder, which, in the opinion of the Principal Investigator, may interfere with the use of the device or compliance with the study protocol;
- Subject has any sleep disorder other than bruxism;
- Subjects who have had direct trauma to the jaw;
- Subjects who have had prior TMJ or ear surgery;
- Subjects who have a narrow ear canal or impression of the ear canal, which is prolapsed due to an anatomical shift or failure of the ear canal wall structure, or a canal that does not allow for the ear canal second turn to be identified;
- Subjects with visible or congenital ear deformity as observed on targeted physical exam;
- Subjects whose ear canal anatomy does not allow for fit of the study device;
- Subjects who have a history of ear pain unrelated to TMJ;
- Subjects who have a history of ear drainage in the past 6 months;
- Subjects who have active ear drainage, swelling, or redness as observed on targeted physical exam;
- Subject has experienced chronic pain (not including migraine pain) associated with sleep bruxism or TMD for more than six months;
- Subject has a pacemaker.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- TMJ Healthlead
- Cardiox Corporationcollaborator
Study Sites (2)
Ear, Nose and Throat Associates of South Florida
Boca Raton, Florida, 33487, United States
Ear, Nose and Throat Associates of South Florida
Boynton Beach, Florida, 33426, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
simon blackburn
Cardiox Corporation
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 2, 2014
First Posted
October 6, 2014
Study Start
November 1, 2014
Primary Completion
February 1, 2015
Study Completion
May 1, 2015
Last Updated
June 10, 2015
Record last verified: 2015-06